❉ Buffybot wonderful businesses, fair prices

← back

MCK McKesson Corporation

healthcare · 2026-09-24

N/A
too hard · 86
Owner-earnings value$915.52
Price$880.50
Margin of safety +4.0%

Quality gate · 86/100

Returns on capital 30/30
Consistency 20.8/22
Margins / pricing power 5.8/16
Balance sheet 13.5/16
Cash conversion 10/10
Capital allocation 6/6

⚠ negative book equity

Median ROIC106.8%
Gross margin3.6%
Net debt / EBITDA0.6x
FCF conversion129%
Share count / yr-4.1%
Profitable years4/4

Moat & management

Owner-earnings inputs

Owner earnings (TTM)4.65B
Owner-earnings yield4.5%
Free-cash-flow yield6.0%
Growth used (normalized)10.0%
Market-implied growth (reverse DCF)9.0%
Terminal growth3.0%
Discount rate (hurdle)9.0%

Projected owner earnings

YrOwner earningsGrowthPV
15.12B 10.0%4.69B
25.59B 9.2%4.70B
36.06B 8.4%4.68B
46.52B 7.7%4.62B
56.97B 6.9%4.53B
67.40B 6.1%4.41B
77.79B 5.3%4.26B
88.15B 4.6%4.09B
98.46B 3.8%3.89B
108.71B 3.0%3.68B

Recent news

score · 8 articles

  • Why McKesson (MCK) Dipped More Than Broader Market Today
  • McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
  • Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?
  • 3 Reasons MCK Has Explosive Upside Potential
  • AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
  • 1 Unpopular Stock That Deserves Some Love and 2 We Turn Down
  • McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know
  • Alluvium Raised Its McKesson (MCK) Stake as Long-Term Growth Expectations Remain Strong

⚠ maintenance capex ≈ min(capex, D&A), capped at FCF · Price pays for ~9%/yr owner-earnings growth over 10y (reverse DCF); model credits 10%.

History

DateQualityPriceValueMoSRating
2026-09-24 86 $880.50 $915.52 +4.0% N/A
2026-08-05 86 $830.43 $933.47 +12.4% N/A
2026-07-02 86 $768.06 $933.47 +21.5% N/A
2026-06-25 86 $766.55 $933.47 +21.8% N/A
2026-06-23 86 $763.91 $933.47 +22.2% N/A